| Year |
Citation |
Score |
| 2024 |
Richardson ME, Holdren M, Brannan T, de la Hoya M, Spurdle AB, Tavtigian SV, Young CC, Zec L, Hiraki S, Anderson MJ, Walker LC, McNulty S, Turnbull C, Tischkowitz M, Schon K, ... ... Monteiro AN, et al. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants. American Journal of Human Genetics. PMID 39317201 DOI: 10.1016/j.ajhg.2024.08.022 |
0.305 |
|
| 2024 |
Dareng EO, Coetzee SG, Tyrer JP, Peng PC, Rosenow W, Chen S, Davis BD, Dezem FS, Seo JH, Nameki R, Reyes AL, Aben KKH, Anton-Culver H, Antonenkova NN, Aravantinos G, ... ... Monteiro AN, et al. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. American Journal of Human Genetics. PMID 38723632 DOI: 10.1016/j.ajhg.2024.04.011 |
0.335 |
|
| 2024 |
Nepomuceno TC, Lyra P, Zhu J, Yi F, Martin RH, Lupu D, Peterson L, Peres LC, Berry A, Iversen ES, Couch FJ, Mo Q, Monteiro AN. Assessment of and Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry. Jco Clinical Cancer Informatics. 8: e2300251. PMID 38709234 DOI: 10.1200/CCI.23.00251 |
0.782 |
|
| 2024 |
Nepomuceno TC, Foo TK, Richardson ME, Ranola JMO, Weyandt J, Varga MJ, Alarcon A, Gutierrez D, von Wachenfeldt A, Eriksson D, Kim R, Armel S, Iversen E, Couch FJ, Borg Å, ... ... Monteiro ANA, et al. BRCA1 frameshift variants leading to extended incorrect protein C termini. Hgg Advances. 5: 100296. PMID 38669137 DOI: 10.1016/j.xhgg.2024.100296 |
0.787 |
|
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Monteiro AN, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.321 |
|
| 2024 |
Hu C, Huang H, Na J, Lumby C, Abozaid M, Holdren MA, Rao TJ, Karam R, Pesaran T, Weyandt JD, Csuy CM, Seelaus CA, Young CC, Fulk K, Heidari Z, ... ... Monteiro ANA, et al. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain. American Journal of Human Genetics. PMID 38417439 DOI: 10.1016/j.ajhg.2024.02.002 |
0.381 |
|
| 2023 |
Huang H, Hu C, Na J, Hart SN, Gnanaolivu RD, Abozaid M, Rao T, Tecleab YA, Pesaran T, Lyra PCM, Karam R, Yadav S, Domchek SM, de la Hoya M, Robson M, ... ... Monteiro ANA, et al. Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants. Biorxiv : the Preprint Server For Biology. PMID 38168194 DOI: 10.1101/2023.12.14.571597 |
0.383 |
|
| 2023 |
Nepomuceno TC, Foo TK, Richardson ME, Ranola JMO, Weyandt J, Varga MJ, Alarcon A, Gutierrez D, von Wachenfeldt A, Eriksson D, Kim R, Armel S, Iversen E, Couch FJ, Borg Å, ... ... Monteiro ANA, et al. BRCA1 frameshift variants leading to extended incorrect protein C-termini. Hgg Advances. 100240. PMID 37718511 DOI: 10.1016/j.xhgg.2023.100240 |
0.827 |
|
| 2023 |
Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, Achatz MI, Ambrosone C, Apostolou P, Arun BK, Auer P, Barnard M, Bertelsen B, Blok MJ, Boddicker N, ... ... Monteiro ANA, et al. ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF14. PMID 37449874 DOI: 10.1158/1078-0432.CCR-23-0212 |
0.347 |
|
| 2022 |
Deng O, Dash S, Nepomuceno TC, Fang B, Yun SY, Welsh EA, Lawrence HR, Marchion D, Koomen JM, Monteiro AN, Rix U. Integrated proteomics identifies PARP inhibitor-induced pro-survival signaling changes as potential vulnerabilities in ovarian cancer. The Journal of Biological Chemistry. 102550. PMID 36183837 DOI: 10.1016/j.jbc.2022.102550 |
0.786 |
|
| 2022 |
Nepomuceno TC, Dos Santos APP, Fernandes VC, Elias ABR, Gomes TT, Suarez-Kurtz G, Iversen ES, Couch FJ, Monteiro ANA, Carvalho MA. Assessment of small in-frame indels and C-terminal nonsense variants of BRCA1 using a validated functional assay. Scientific Reports. 12: 16203. PMID 36171434 DOI: 10.1038/s41598-022-20500-4 |
0.83 |
|
| 2022 |
Abreu RBV, Gomes TT, Nepomuceno TC, Li X, Fuchshuber-Moraes M, De Gregoriis G, Suarez-Kurtz G, Monteiro ANA, Carvalho MA. Functional Restoration of Nonsense Mutations by Aminoglycoside-Induced Readthrough. Frontiers in Pharmacology. 13: 935995. PMID 35837282 DOI: 10.3389/fphar.2022.935995 |
0.828 |
|
| 2022 |
Xia B, Biswas K, Foo TK, Torres T, Riedel-Topper M, Southon E, Kang Z, Huo Y, Reid S, Stauffer S, Zhou W, Zhu B, Koka H, Yepes S, Brodie SA, ... ... Monteiro AN, et al. Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma. Human Mutation. PMID 35762214 DOI: 10.1002/humu.24427 |
0.698 |
|
| 2022 |
Hu C, Susswein LR, Roberts ME, Yang H, Marshall ML, Hiraki S, Berkofsky-Fessler W, Gupta S, Shen W, Dunn CA, Huang H, Na J, Domchek SM, Yadav S, Monteiro ANA, et al. Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology directed repair (HDR) functional assay. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35736817 DOI: 10.1158/1078-0432.CCR-22-0203 |
0.356 |
|
| 2022 |
Iversen ES, Lipton G, Hart SN, Lee KY, Hu C, Polley EC, Pesaran T, Yussuf A, LaDuca H, Chao E, Karam R, Goldgar DE, Couch FJ, Monteiro ANA. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance. Npj Genomic Medicine. 7: 35. PMID 35665744 DOI: 10.1038/s41525-022-00302-3 |
0.402 |
|
| 2022 |
Fasching PA, Liu D, Scully S, Ingle JN, Lyra PC, Rack B, Hein A, Ekici AB, Reis A, Schneeweiss A, Tesch H, Fehm TN, Heinrich G, Beckmann MW, Ruebner M, ... ... Monteiro ANA, et al. Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35653140 DOI: 10.1158/1078-0432.CCR-20-4774 |
0.805 |
|
| 2021 |
Mendoza-Fandiño G, Lyra PCM, Nepomuceno TC, Harro CM, Woods NT, Li X, Rangel LB, Carvalho MA, Couch FJ, Monteiro ANA. Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. European Journal of Human Genetics : Ejhg. PMID 34803163 DOI: 10.1038/s41431-021-01005-6 |
0.816 |
|
| 2021 |
Peres LC, Monteiro AN. Scratching Below the Ovarian Cancer GWAS Surface. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 30: 1604-1606. PMID 34475121 DOI: 10.1158/1055-9965.EPI-21-0568 |
0.321 |
|
| 2021 |
Dash S, Yoder S, Mesa T, Smith A, Cen L, Eschrich S, Armaiz-Pena GN, Monteiro ANA. Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells. Scientific Reports. 11: 14334. PMID 34253763 DOI: 10.1038/s41598-021-93506-z |
0.799 |
|
| 2021 |
Dash S, Yoder S, Mesa T, Smith A, Cen L, Eschrich S, Armaiz-Pena GN, Monteiro ANA. Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells. Scientific Reports. 11: 14334. PMID 34253763 DOI: 10.1038/s41598-021-93506-z |
0.799 |
|
| 2021 |
Richardson ME, Hu C, Lee KY, LaDuca H, Fulk K, Durda KM, Deckman AM, Goldgar DE, Monteiro ANA, Gnanaolivu R, Hart SN, Polley EC, Chao E, Pesaran T, Couch FJ. Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance. American Journal of Human Genetics. PMID 33609447 DOI: 10.1016/j.ajhg.2021.02.005 |
0.334 |
|
| 2020 |
Nepomuceno TC, Carvalho MA, Rodrigue A, Simard J, Masson JY, Monteiro ANA. PALB2 Variants: Protein Domains and Cancer Susceptibility. Trends in Cancer. PMID 33139182 DOI: 10.1016/j.trecan.2020.10.002 |
0.837 |
|
| 2020 |
Lyra PCM, Nepomuceno TC, de Souza MLM, Machado GF, Veloso MF, Henriques TB, Dos Santos DZ, Ribeiro IG, Ribeiro RS, Rangel LBA, Richardson M, Iversen ES, Goldgar D, Couch FJ, Carvalho MA, ... Monteiro ANA, et al. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33087888 DOI: 10.1038/s41436-020-00991-0 |
0.823 |
|
| 2020 |
Monteiro AN, Bouwman P, Kousholt AN, Eccles DM, Millot GA, Masson JY, Schmidt MK, Sharan SK, Scully R, Wiesmüller L, Couch F, Vreeswijk MPG. Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation. Journal of Medical Genetics. PMID 32152249 DOI: 10.1136/Jmedgenet-2019-106368 |
0.404 |
|
| 2020 |
Golubeva VA, Nepomuceno TC, Gregoriis G, Mesquita RD, Li X, Dash S, Garcez PP, Suarez-Kurtz G, Izumi V, Koomen J, Carvalho MA, Monteiro ANA. Network of Interactions between ZIKA Virus Non-Structural Proteins and Human Host Proteins. Cells. 9. PMID 31936331 DOI: 10.3390/Cells9010153 |
0.765 |
|
| 2020 |
Lyra PCM, Rangel LB, Monteiro ANA. Functional Landscape of Common Variants Associated with Susceptibility to Epithelial Ovarian Cancer Current Epidemiology Reports. 7: 49-57. DOI: 10.1007/s40471-020-00227-4 |
0.331 |
|
| 2019 |
Dutil J, Teer JK, Golubeva V, Yoder S, Tong WL, Arroyo N, Karam R, Echenique M, Matta JL, Monteiro AN. Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico. Scientific Reports. 9: 17769. PMID 31780696 DOI: 10.1038/s41598-019-54170-6 |
0.387 |
|
| 2019 |
Mota MBS, Carvalho MA, Monteiro ANA, Mesquita RD. DNA damage response and repair in perspective: Aedes aegypti, Drosophila melanogaster and Homo sapiens. Parasites & Vectors. 12: 533. PMID 31711518 DOI: 10.1186/s13071-019-3792-1 |
0.644 |
|
| 2019 |
Wiltshire T, Ducy M, Foo TK, Hu C, Lee KY, Belur Nagaraj A, Rodrigue A, Gomes TT, Simard J, Monteiro ANA, Xia B, Carvalho MA, Masson JY, Couch FJ. Functional characterization of 84 PALB2 variants of uncertain significance. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31636395 DOI: 10.1038/S41436-019-0682-Z |
0.71 |
|
| 2019 |
Rodrigue A, Margaillan G, Torres Gomes T, Coulombe Y, Montalban G, da Costa E Silva Carvalho S, Milano L, Ducy M, De-Gregoriis G, Dellaire G, Araújo da Silva W, Monteiro AN, Carvalho MA, Simard J, Masson JY. A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor. Nucleic Acids Research. PMID 31586400 DOI: 10.1093/nar/gkz780 |
0.684 |
|
| 2019 |
Hu WF, Krieger KL, Lagundžin D, Li X, Cheung RS, Taniguchi T, Johnson KR, Bessho T, Monteiro ANA, Woods NT. CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. Cell Death Discovery. 5: 105. PMID 31240132 DOI: 10.1038/S41420-019-0185-3 |
0.705 |
|
| 2019 |
Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadaló L, Aalfs CM, Agata S, Aittomäki K, Alducci E, Alonso-Cerezo MC, Arnold N, Auber B, Austin R, Azzollini J, ... ... Monteiro AN, et al. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Human Mutation. PMID 31131967 DOI: 10.1002/Humu.23818 |
0.326 |
|
| 2019 |
Gusev A, Lawrenson K, Lin X, Lyra PC, Kar S, Vavra KC, Segato F, Fonseca MAS, Lee JM, Pejovic T, Liu G, Karlan BY, Freedman ML, Noushmehr H, ... Monteiro AN, et al. A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants. Nature Genetics. PMID 31043753 DOI: 10.1038/S41588-019-0395-X |
0.81 |
|
| 2019 |
Golubeva VA, Nepomuceno TC, Monteiro ANA. Germline Missense Variants in : New Trends and Challenges for Clinical Annotation. Cancers. 11. PMID 31013702 DOI: 10.3390/cancers11040522 |
0.801 |
|
| 2019 |
Spurdle AB, Greville-Heygate S, Antoniou AC, Brown M, Burke L, de la Hoya M, Domchek S, Dörk T, Firth HV, Monteiro AN, Mensenkamp A, Parsons MT, Radice P, Robson M, Tischkowitz M, et al. Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report. Journal of Medical Genetics. PMID 30962250 DOI: 10.1136/Jmedgenet-2018-105872 |
0.307 |
|
| 2019 |
Reid BM, Permuth JB, Chen YA, Fridley BL, Iversen ES, Chen Z, Jim H, Vierkant RA, Cunningham JM, Barnholtz-Sloan JS, Narod S, Risch H, Schildkraut JM, Goode EL, Monteiro AN, et al. Genome-wide analysis of common copy number variation and epithelial ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30948450 DOI: 10.1158/1055-9965.Epi-18-0833 |
0.311 |
|
| 2019 |
Dutil J, Chen Z, Monteiro AN, Teer JK, Eschrich SA. An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. Cancer Research. PMID 30894373 DOI: 10.1158/0008-5472.Can-18-2747 |
0.31 |
|
| 2019 |
Fernandes VC, Golubeva VA, Di Pietro G, Shields C, Amankwah K, Nepomuceno TC, de Gregoriis G, Abreu RBV, Harro C, Gomes TT, Silva RF, Suarez-Kurtz G, Couch F, Iversen ES, Monteiro ANA, et al. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation. The Journal of Biological Chemistry. PMID 30765603 DOI: 10.1074/Jbc.Ra118.005274 |
0.827 |
|
| 2018 |
Nielsen SM, Eccles DM, Romero IL, Al-Mulla F, Balmaña J, Biancolella M, Bslok R, Caligo MA, Calvello M, Capone GL, Cavalli P, Chan TLC, Claes KBM, Cortesi L, Couch FJ, ... ... Monteiro AN, et al. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group. Jco Precision Oncology. 2. PMID 31517176 DOI: 10.1200/PO.18.00091 |
0.312 |
|
| 2018 |
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder S, ... ... Monteiro AN, et al. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research. PMID 30487138 DOI: 10.1158/0008-5472.Can-17-3864 |
0.799 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Monteiro ANA, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.352 |
|
| 2018 |
Gjyshi A, Dash S, Cen L, Cheng CH, Zhang C, Yoder SJ, Teer JK, Armaiz-Pena GN, Monteiro ANA. Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Scientific Reports. 8: 8291. PMID 29844388 DOI: 10.1038/s41598-018-26670-4 |
0.79 |
|
| 2018 |
Guidugli L, Shimelis H, Masica DL, Pankratz VS, Lipton GB, Singh N, Hu C, Monteiro ANA, Lindor NM, Goldgar DE, Karchin R, Iversen ES, Couch FJ. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches. American Journal of Human Genetics. PMID 29394989 DOI: 10.1016/J.Ajhg.2017.12.013 |
0.322 |
|
| 2018 |
Nielsen S, Nicolo AD, Eccles D, Romero IL, Domchek SM, Monteiro A, Goldgar D, Spurdle A, Garcia EG. Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the Enigma Clinical Working Group. Journal of Clinical Oncology. 36: 1539-1539. DOI: 10.1200/Jco.2018.36.15_Suppl.1539 |
0.416 |
|
| 2017 |
Nepomuceno TC, De Gregoriis G, de Oliveira FMB, Suarez-Kurtz G, Monteiro AN, Carvalho MA. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition. International Journal of Molecular Sciences. 18. PMID 28858227 DOI: 10.3390/ijms18091886 |
0.824 |
|
| 2017 |
Teer JK, Yoder S, Gjyshi A, Nicosia SV, Zhang C, Monteiro ANA. Mutational heterogeneity in non-serous ovarian cancers. Scientific Reports. 7: 9728. PMID 28852190 DOI: 10.1038/S41598-017-10432-9 |
0.8 |
|
| 2017 |
Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, Dennis J, Pirie A, Riggan MJ, Chornokur G, Earp MA, Lyra PC, Lee JM, Coetzee S, Beesley J, ... ... Monteiro AN, et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics. PMID 28346442 DOI: 10.1038/ng.3826 |
0.791 |
|
| 2017 |
Shimelis H, Mesman RL, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calleja FM, Meeks H, Hallberg E, Hinton J, Lilyquist J, Hu C, Aalfs CM, Aittomaki K, Andrulis IL, ... ... Monteiro AN, et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Research. PMID 28283652 DOI: 10.1158/0008-5472.Can-16-2568 |
0.336 |
|
| 2017 |
Nepomuceno TC, Fernandes VC, Gomes TT, Carvalho RS, Suarez-Kurtz G, Monteiro AN, Carvalho MA. BRCA1 recruitment to damaged DNA sites is dependent on CDK9. Cell Cycle (Georgetown, Tex.). 1-8. PMID 28278048 DOI: 10.1080/15384101.2017.1295177 |
0.8 |
|
| 2017 |
Harro CM, Monteiro AN. Dissecting genetic risk factors in breast cancer. Oncotarget. PMID 28177912 DOI: 10.18632/oncotarget.15089 |
0.304 |
|
| 2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... ... Monteiro AN, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.349 |
|
| 2017 |
Gray JE, Tanvetyanon T, Creelan BC, Antonia SJ, Haura EB, Williams CC, Yaseen R, Schell MJ, Godin R, Rix U, Monteiro A. Phase II trial of AZD1775 in combination with carboplatin and paclitaxel in stage IV squamous cell lung cancer (sqNSCLC): Preliminary results. Journal of Clinical Oncology. 35: e20672-e20672. DOI: 10.1200/Jco.2017.35.15_Suppl.E20672 |
0.32 |
|
| 2016 |
Woods NT, Baskin R, Golubeva V, Jhuraney A, De-Gregoriis G, Vaclova T, Goldgar DE, Couch FJ, Carvalho MA, Iversen ES, Monteiro AN. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. Npj Genomic Medicine. 1. PMID 28781887 DOI: 10.1038/Npjgenmed.2016.1 |
0.809 |
|
| 2016 |
Reid BM, Permuth JB, Chen YA, Teer JK, Monteiro AN, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA, Goode EL, Iverson ES, Lawrenson K, et al. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28035019 DOI: 10.1158/1055-9965.EPI-16-0341 |
0.33 |
|
| 2016 |
Vaclová T, Woods NT, Megías D, Gomez-Lopez S, Setién F, García Bueno JM, Macías JA, Barroso A, Urioste M, Esteller M, Monteiro AN, Benítez J, Osorio A. Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor Olaparib by a dominant negative effect. Human Molecular Genetics. PMID 27742776 DOI: 10.1093/Hmg/Ddw343 |
0.704 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... ... Monteiro AN, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.742 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Monteiro AN, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.722 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Monteiro A, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.48 |
|
| 2016 |
Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 |
0.422 |
|
| 2016 |
Jhuraney A, Woods NT, Wright G, Rix L, Kinose F, Kroeger JL, Remily-Wood E, Cress WD, Koomen JM, Brantley SG, Gray JE, Haura EB, Rix U, Monteiro AN. PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer. Molecular Cancer Therapeutics. PMID 27196765 DOI: 10.1158/1535-7163.Mct-15-0182 |
0.8 |
|
| 2016 |
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, ... ... Monteiro AA, et al. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 7: 11375. PMID 27117709 DOI: 10.1038/Ncomms11375 |
0.332 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.35 |
|
| 2016 |
Buckley M, Gjyshi A, Mendoza-Fandiño G, Baskin R, Carvalho RS, Carvalho MA, Woods NT, Monteiro AN. Enhancer scanning to locate regulatory regions in genomic loci. Nature Protocols. 11: 46-60. PMID 26658467 DOI: 10.1038/Nprot.2015.136 |
0.78 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Monteiro AN, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.736 |
|
| 2016 |
Gjyshi A, Mendoza-Fandino G, Woods N, Tyrer J, Lawrenson K, Buckley M, Shen H, Carvalho R, Seo J, Phelan C, Freedman M, Goode E, Sellers T, Gayther S, Pharoah P, ... Monteiro A, et al. Abstract PR15: MYC distal enhancers underlie ovarian cancer susceptibility in the 8q24.21 locus. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-Pr15 |
0.815 |
|
| 2016 |
Teer J, Yoder S, Gjyshi A, Zhang C, Monteiro A. Abstract B11: Mutational heterogeneity in non-serous ovarian cancers. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B11 |
0.81 |
|
| 2016 |
Chornokur G, Lin H, Monteiro A, Schildkraut J, Goode EL, Pharoah PD, Gayther SA, Ramus S, Sellers TA, Phelan CM. Abstract A50: Mitochondrial metabolism gene variants are associated with risk and survival in epithelial ovarian cancer (EOC) Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A50 |
0.409 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Monteiro AN, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.349 |
|
| 2015 |
Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Scientific Reports. 5: 17367. PMID 26610392 DOI: 10.1038/Srep17367 |
0.691 |
|
| 2015 |
Richards EJ, Permuth-Wey J, Li Y, Chen YA, Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, Lawrenson K, Monteiro AN, Schildkraut JM, Goode EL, Gayther SA, et al. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. Oncotarget. PMID 26430965 DOI: 10.18632/Oncotarget.5784 |
0.311 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Monteiro AN, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.328 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Monteiro AN, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.304 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Monteiro A, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.448 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Monteiro AN, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.306 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Monteiro AN, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.352 |
|
| 2015 |
Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, ... Monteiro AN, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101 |
0.371 |
|
| 2015 |
Jhuraney A, Velkova A, Johnson RC, Kessing B, Carvalho RS, Whiley P, Spurdle AB, Vreeswijk MP, Caputo SM, Millot GA, Vega A, Coquelle N, Galli A, Eccles D, Blok MJ, ... ... Monteiro AN, et al. BRCA1 Circos: a visualisation resource for functional analysis of missense variants. Journal of Medical Genetics. 52: 224-30. PMID 25643705 DOI: 10.1136/Jmedgenet-2014-102766 |
0.814 |
|
| 2015 |
Woods NT, Monteiro AN, Thompson ZJ, Amankwah EK, Naas N, Haura EB, Beg AA, Schabath MB. Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients. Molecular Carcinogenesis. 54: E172-84. PMID 25597281 DOI: 10.1002/Mc.22275 |
0.648 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Monteiro AN, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.359 |
|
| 2015 |
Woods NT, Jhuraney A, Monteiro AN. Incorporating computational resources in a cancer research program. Human Genetics. 134: 467-78. PMID 25324189 DOI: 10.1007/S00439-014-1496-3 |
0.777 |
|
| 2015 |
Permuth-Wey J, Reid BM, Chen YA, Lin H, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode E, Iversen E, Pearce L, Pharoah PDP, Phelan C, et al. Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility Cancer Research. 75: 4635-4635. DOI: 10.1158/1538-7445.Am2015-4635 |
0.437 |
|
| 2015 |
Reid BM, Permuth-Wey J, Chen YA, Lin H, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode EL, Iversen E, Pearce L, Pharoah P, Phelan C, et al. Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk Cancer Research. 75: 4634-4634. DOI: 10.1158/1538-7445.Am2015-4634 |
0.466 |
|
| 2015 |
Sellers TA, Reid BM, Chen YA, Lin H, Richards E, Teer J, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Goode E, Iverson E, Pearce L, Pharoah P, et al. Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk Cancer Research. 75: 4633-4633. DOI: 10.1158/1538-7445.Am2015-4633 |
0.429 |
|
| 2015 |
Baskin R, Woods N, Mendoza-Fandino G, Forsyth P, Egan K, Monteiro A. Abstract 3951: Functional analysis of the 11q23.3 glioma susceptibility locus Cancer Research. 75: 3951-3951. DOI: 10.1158/1538-7445.Am2015-3951 |
0.726 |
|
| 2015 |
Nepomuceno T, Fernandes V, Gomes T, Gregoris GD, Carvalho R, Kurtz G, Monteiro Á, Carvalho MA. Abstract 3025: Characterization of CDK9/BRCA1 complex in DNA damage response Cancer Research. 75: 3025-3025. DOI: 10.1158/1538-7445.Am2015-3025 |
0.734 |
|
| 2015 |
Lawrenson K, Kar S, Kuckenbaeker K, Edwards S, Li Q, Tyrer J, Beesley J, Michailidou K, Ramus S, Dunning A, Couch F, Monteiro A, Simard J, Freedman M, Easton D, et al. Abstract 2783: Common functional mechanisms underlying pleiotropy at the 19p13.1 breast and ovarian cancer cusceptibility locus Cancer Research. 75: 2783-2783. DOI: 10.1158/1538-7445.Am2015-2783 |
0.487 |
|
| 2014 |
Carvalho RS, Abreu RBV, Velkova A, Marsillac S, Rodarte RS, Suarez-Kurtz G, Iversen ES, Monteiro ANA, Carvalho MA. Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1 Plos One. 9. PMID 24845084 DOI: 10.1371/Journal.Pone.0097766 |
0.812 |
|
| 2014 |
Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology & Therapy. 15: 840-50. PMID 24755837 DOI: 10.4161/Cbt.28873 |
0.808 |
|
| 2014 |
Guidugli L, Carreira A, Caputo SM, Ehlen A, Galli A, Monteiro AN, Neuhausen SL, Hansen TV, Couch FJ, Vreeswijk MP. Functional assays for analysis of variants of uncertain significance in BRCA2. Human Mutation. 35: 151-64. PMID 24323938 DOI: 10.1002/humu.22478 |
0.423 |
|
| 2013 |
Tulchin N, Ornstein L, Dikman S, Strauchen J, Jaffer S, Nagi C, Bleiweiss I, Kornreich R, Edelmann L, Brown K, Bodian C, Nair VD, Chambon M, Woods NT, Monteiro AN. Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell International. 13: 70. PMID 23855721 DOI: 10.1186/1475-2867-13-70 |
0.724 |
|
| 2013 |
Quiles F, Fernández-Rodríguez J, Mosca R, Feliubadaló L, Tornero E, Brunet J, Blanco I, Capellá G, Pujana MÀ, Aloy P, Monteiro A, Lázaro C. Functional and structural analysis of C-terminal BRCA1 missense variants. Plos One. 8: e61302. PMID 23613828 DOI: 10.1371/Journal.Pone.0061302 |
0.463 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Monteiro AN, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.704 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Monteiro AN, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.81 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Monteiro AN, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.349 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Monteiro AN, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.682 |
|
| 2013 |
Domchek SM, Tang J, Stopfer J, Lilli DR, Hamel N, Tischkowitz M, Monteiro AN, Messick TE, Powers J, Yonker A, Couch FJ, Goldgar DE, Davidson HR, Nathanson KL, Foulkes WD, et al. Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer. Cancer Discovery. 3: 399-405. PMID 23269703 DOI: 10.1158/2159-8290.Cd-12-0421 |
0.351 |
|
| 2013 |
Jim H, Tyrer J, Lin H, Han G, Qu X, Goode EL, Chen Z, Tsai Y, Cunningham JM, Iversen E, Ramus S, Berchuck A, Schildkraut J, Monteiro A, Gayther S, et al. Abstract 4850: Variation in circadian rhythm genes influence epithelial ovarian cancer risk and invasiveness. Cancer Research. 73: 4850-4850. DOI: 10.1158/1538-7445.Am2013-4850 |
0.419 |
|
| 2013 |
Chen YA, Chen Z, Permuth-Wey J, Tsai Y, Lin H, Qu X, Lawrenson K, Fenstermacher D, Phelan CM, Monteiro A, Gayther SA, Narod SA, Sutphen R, Birrer MJ, Wentzensen N, et al. Abstract 4579: Variants in long non-coding RNAs are associated with epithelial ovarian cancer risk in a pooled analysis of three genome-wide association studies. Cancer Research. 73: 4579-4579. DOI: 10.1158/1538-7445.Am2013-4579 |
0.423 |
|
| 2013 |
Chornokur G, Tyrer J, Lin H, Han G, Qu X, Zhihua C, Tsai Y, Goode EL, Cunningham JM, Iversen E, Ramus SJ, Berchuk A, Schildkraut JM, Monteiro A, Gayther SA, et al. Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype. Cancer Research. 73: 3644-3644. DOI: 10.1158/1538-7445.Am2013-3644 |
0.392 |
|
| 2013 |
Amankwah EK, Tyrer J, Lin H, Tsai Y, Chen Z, Han G, Qu X, Goode E, Cunninghan J, Iverson E, Ramus S, Berchuck A, Schildkraut J, Monteiro A, Gayther S, et al. Abstract 1352: Epithelial-mesenchymal transition (EMT) gene variants influence epithelial ovarian cancer risk in women of European, African and Asian ancestry. Cancer Research. 73: 1352-1352. DOI: 10.1158/1538-7445.Am2013-1352 |
0.413 |
|
| 2012 |
Woods NT, Mesquita RD, Sweet M, Carvalho MA, Li X, Liu Y, Nguyen H, Thomas CE, Iversen ES, Marsillac S, Karchin R, Koomen J, Monteiro AN. Charting the landscape of tandem BRCT domain-mediated protein interactions. Science Signaling. 5: rs6. PMID 22990118 DOI: 10.1126/Scisignal.2002255 |
0.791 |
|
| 2012 |
Millot GA, Carvalho MA, Caputo SM, Vreeswijk MP, Brown MA, Webb M, Rouleau E, Neuhausen SL, Hansen Tv, Galli A, Brandão RD, Blok MJ, Velkova A, Couch FJ, Monteiro AN, et al. A guide for functional analysis of BRCA1 variants of uncertain significance. Human Mutation. 33: 1526-37. PMID 22753008 DOI: 10.1002/Humu.22150 |
0.823 |
|
| 2012 |
Gerloff DL, Woods NT, Farago AA, Monteiro AN. BRCT domains: A little more than kin, and less than kind. Febs Letters. 586: 2711-6. PMID 22584059 DOI: 10.1016/J.Febslet.2012.05.005 |
0.66 |
|
| 2012 |
Velkova A, Monteiro AN. CHEKing out of mitosis. Cell Cycle (Georgetown, Tex.). 11: 1756. PMID 22510558 DOI: 10.4161/Cc.20315 |
0.57 |
|
| 2012 |
Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, Radice P, Stoppa-Lyonnet D, Tavtigian S, Wappenschmidt B, Couch FJ, Goldgar DE. ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Human Mutation. 33: 2-7. PMID 21990146 DOI: 10.1002/Humu.21628 |
0.331 |
|
| 2012 |
Lindor NM, Guidugli L, Wang X, Vallée MP, Monteiro AN, Tavtigian S, Goldgar DE, Couch FJ. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS). Human Mutation. 33: 8-21. PMID 21990134 DOI: 10.1002/Humu.21627 |
0.348 |
|
| 2012 |
Matta JL, Morales L, Acosta H, Dutil J, Monteiro A, Alvarez-Garriga C, Bayona M. Abstract 3095: The host cell reactivation (HCR) assay for measuring DNA repair capacity (DRC) in cancer research after 20 years; re-evaluation and lessons learned Cancer Research. 72: 3095-3095. DOI: 10.1158/1538-7445.Am2012-3095 |
0.349 |
|
| 2012 |
Permuth-Wey J, Lin H, Tsai Y, Zhihua C, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock S, Cramer DW, Cunningham JM, Fenstermacher D, Fridley B, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, ... ... Monteiro A, et al. Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study Cancer Research. 72: 2927-2927. DOI: 10.1158/1538-7445.Am2012-2927 |
0.391 |
|
| 2011 |
Velkova A, Monteiro AN. Epigenetic tumor suppression by BRCA1. Nature Medicine. 17: 1183-5. PMID 21988990 DOI: 10.1038/Nm.2493 |
0.687 |
|
| 2011 |
Liu Y, Woods NT, Kim D, Sweet M, Monteiro AN, Karchin R. Yeast two-hybrid junk sequences contain selected linear motifs. Nucleic Acids Research. 39: e128. PMID 21785140 DOI: 10.1093/Nar/Gkr600 |
0.622 |
|
| 2011 |
Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, Plass C, Casey G, De Biasi M, Carlson C, Duggan D, James M, Liu P, Tichelaar JW, Vikis HG, You M, et al. Principles for the post-GWAS functional characterization of cancer risk loci. Nature Genetics. 43: 513-8. PMID 21614091 DOI: 10.1038/Ng.840 |
0.387 |
|
| 2011 |
Iversen ES, Couch FJ, Goldgar DE, Tavtigian SV, Monteiro AN. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1078-88. PMID 21447777 DOI: 10.1158/1055-9965.Epi-10-1214 |
0.318 |
|
| 2011 |
Woods NT, Nguyen H, Carvalho M, Li X, Dapic V, Monteiro A. Abstract 3892: Discovery and analysis of COMMD1 in the DNA damage response network Cancer Research. 71: 3892-3892. DOI: 10.1158/1538-7445.Am2011-3892 |
0.815 |
|
| 2010 |
Mesquita RD, Woods NT, Seabra-Junior ES, Monteiro AN. Tandem BRCT Domains: DNA's Praetorian Guard. Genes & Cancer. 1: 1140-6. PMID 21533002 DOI: 10.1177/1947601910392988 |
0.685 |
|
| 2010 |
Freeman AK, Monteiro AN. Phosphatases in the cellular response to DNA damage. Cell Communication and Signaling : Ccs. 8: 27. PMID 20860841 DOI: 10.1186/1478-811X-8-27 |
0.728 |
|
| 2010 |
Lee MS, Green R, Marsillac SM, Coquelle N, Williams RS, Yeung T, Foo D, Hau DD, Hui B, Monteiro AN, Glover JN. Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Research. 70: 4880-90. PMID 20516115 DOI: 10.1158/0008-5472.Can-09-4563 |
0.404 |
|
| 2010 |
Velkova A, Carvalho MA, Johnson JO, Tavtigian SV, Monteiro AN. Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. Cell Cycle (Georgetown, Tex.). 9: 1421-33. PMID 20305393 DOI: 10.4161/Cc.9.7.11256 |
0.797 |
|
| 2010 |
Freeman AK, Dapic V, Monteiro AN. Negative regulation of CHK2 activity by protein phosphatase 2A is modulated by DNA damage. Cell Cycle (Georgetown, Tex.). 9: 736-47. PMID 20160490 DOI: 10.4161/Cc.9.4.10613 |
0.721 |
|
| 2010 |
Tulchin N, Chambon M, Juan G, Dikman S, Strauchen J, Ornstein L, Billack B, Woods NT, Monteiro AN. BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. The American Journal of Pathology. 176: 1203-14. PMID 20075200 DOI: 10.2353/Ajpath.2010.081063 |
0.812 |
|
| 2009 |
De Ligio JT, Velkova A, Zorio DA, Monteiro AN. Can the status of the breast and ovarian cancer susceptibility gene 1 product (BRCA1) predict response to taxane-based cancer therapy? Anti-Cancer Agents in Medicinal Chemistry. 9: 543-9. PMID 19519295 DOI: 10.2174/187152009788451798 |
0.684 |
|
| 2009 |
Rios-Doria J, Velkova A, Dapic V, Galán-Caridad JM, Dapic V, Carvalho MA, Melendez J, Monteiro AN. Ectopic expression of histone H2AX mutants reveals a role for its post-translational modifications. Cancer Biology & Therapy. 8: 422-34. PMID 19305155 DOI: 10.4161/Cbt.8.5.7592 |
0.767 |
|
| 2009 |
Yamaguchi H, Woods NT, Piluso LG, Lee HH, Chen J, Bhalla KN, Monteiro A, Liu X, Hung MC, Wang HG. p53 acetylation is crucial for its transcription-independent proapoptotic functions. The Journal of Biological Chemistry. 284: 11171-83. PMID 19265193 DOI: 10.1074/Jbc.M809268200 |
0.732 |
|
| 2009 |
Carvalho M, Pino MA, Karchin R, Beddor J, Godinho-Netto M, Mesquita RD, Rodarte RS, Vaz DC, Monteiro VA, Manoukian S, Colombo M, Ripamonti CB, Rosenquist R, Suthers G, Borg A, ... ... Monteiro AN, et al. Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1. Mutation Research. 660: 1-11. PMID 18992264 DOI: 10.1016/J.Mrfmmm.2008.09.017 |
0.823 |
|
| 2008 |
Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA, Nederlof PM, Goldgar DE, Tavtigian SV, ... Monteiro AN, et al. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach. European Journal of Human Genetics : Ejhg. 16: 820-32. PMID 18285836 DOI: 10.1038/ejhg.2008.13 |
0.735 |
|
| 2007 |
Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. American Journal of Human Genetics. 81: 873-83. PMID 17924331 DOI: 10.1086/521032 |
0.388 |
|
| 2007 |
Carvalho MA, Monteiro AN. Correction: functional analysis of BRCA1 M1628V variant. Journal of Medical Genetics. 44: e78. PMID 17311832 DOI: 10.1136/jmg.2006.045344 |
0.676 |
|
| 2007 |
Carvalho MA, Marsillac SM, Karchin R, Manoukian S, Grist S, Swaby RF, Urmenyi TP, Rondinelli E, Silva R, Gayol L, Baumbach L, Sutphen R, Pickard-Brzosowicz JL, Nathanson KL, Sali A, ... ... Monteiro AN, et al. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Research. 67: 1494-501. PMID 17308087 DOI: 10.1158/0008-5472.Can-06-3297 |
0.754 |
|
| 2007 |
Karchin R, Monteiro AN, Tavtigian SV, Carvalho MA, Sali A. Functional impact of missense variants in BRCA1 predicted by supervised learning. Plos Computational Biology. 3: e26. PMID 17305420 DOI: 10.1371/Journal.Pcbi.0030026 |
0.703 |
|
| 2007 |
Gomes MC, Costa MM, Borojevic R, Monteiro AN, Vieira R, Koifman S, Koifman RJ, Li S, Royer R, Zhang S, Narod SA. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. Breast Cancer Research and Treatment. 103: 349-53. PMID 17063270 DOI: 10.1007/S10549-006-9378-6 |
0.561 |
|
| 2007 |
Carvalho MA, Couch FJ, Monteiro AN. Functional assays for BRCA1 and BRCA2. The International Journal of Biochemistry & Cell Biology. 39: 298-310. PMID 16978908 DOI: 10.1016/j.biocel.2006.08.002 |
0.711 |
|
| 2006 |
Dapić V, Monteiro AN. Functional implications of BRCA1 for early detection, prevention, and treatment of breast cancer. Critical Reviews in Eukaryotic Gene Expression. 16: 233-52. PMID 17073553 |
0.362 |
|
| 2006 |
Kaufman B, Laitman Y, Carvalho MA, Edelman L, Menachem TD, Zidan J, Monteiro AN, Friedman E. The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews. Genetic Testing. 10: 200-7. PMID 17020472 DOI: 10.1089/gte.2006.10.200 |
0.659 |
|
| 2006 |
Chiarini LB, Takiya CM, Borojevic R, Monteiro AN. Long-term culture of cholangiocytes from liver fibro-granulomatous lesions. Bmc Gastroenterology. 6: 13. PMID 16584555 DOI: 10.1186/1471-230X-6-13 |
0.717 |
|
| 2006 |
Rios-Doria J, Fay A, Velkova A, Monteiro AN. DNA damage response: determining the fate of phosphorylated histone H2AX. Cancer Biology & Therapy. 5: 142-4. PMID 16552174 DOI: 10.4161/Cbt.5.2.2530 |
0.618 |
|
| 2006 |
Monteiro AN, Couch FJ. Cancer risk assessment at the atomic level. Cancer Research. 66: 1897-9. PMID 16488985 DOI: 10.1158/0008-5472.CAN-05-3034 |
0.328 |
|
| 2005 |
Billack B, Monteiro AN. BRCA1 in breast and ovarian cancer predisposition. Cancer Letters. 227: 1-7. PMID 16051027 DOI: 10.1016/j.canlet.2004.11.006 |
0.743 |
|
| 2005 |
Dapic V, Carvalho MA, Monteiro AN. Breast cancer susceptibility and the DNA damage response. Cancer Control : Journal of the Moffitt Cancer Center. 12: 127-36. PMID 15855896 |
0.695 |
|
| 2004 |
Geremias AT, Carvalho MA, Borojevic R, Monteiro AN. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells. Bmc Gastroenterology. 4: 30. PMID 15579200 DOI: 10.1186/1471-230X-4-30 |
0.691 |
|
| 2004 |
Szabo CI, Worley T, Monteiro AN. Understanding germ-line mutations in BRCA1. Cancer Biology & Therapy. 3: 515-20. PMID 15254424 |
0.366 |
|
| 2004 |
Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Research. 64: 3790-7. PMID 15172985 DOI: 10.1158/0008-5472.Can-03-3009 |
0.342 |
|
| 2004 |
Billack B, Monteiro AN. Methods to classify BRCA1 variants of uncertain clinical significance: the more the merrier. Cancer Biology & Therapy. 3: 458-9. PMID 15118412 |
0.652 |
|
| 2002 |
Carvalho MA, Billack B, Chan E, Worley T, Cayanan C, Monteiro AN. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation. Cancer Biology & Therapy. 1: 502-8. PMID 12496477 |
0.809 |
|
| 2002 |
Worley T, Vallon-Christersson J, Billack B, Borg A, Monteiro AN. A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein. Cancer Biology & Therapy. 1: 497-501. PMID 12496476 |
0.717 |
|
| 2000 |
Monteiro ANA. BRCA1: Exploring the links to transcription Trends in Biochemical Sciences. 25: 469-474. PMID 11050427 DOI: 10.1016/S0968-0004(00)01632-7 |
0.339 |
|
| Show low-probability matches. |